Director, Patient Safety (MD)

Gilead Sciences, Inc.

Where
United States - New Jersey - Parsippany
Pay
$221K a year

Posted 16 days ago· Checked live at Gilead Sciences, Inc. 4 days ago

Live.Open on the employer's own site.

See how you score for this job

One sentence and your resume. We score it against what Gilead Sciences, Inc. asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on Gilead Sciences, Inc.'s own hiring page 4 days ago.
What is the job?
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.
What does it pay?
$221K a year, as the posting states.
Our verdict
Live. Open on the employer's own site.

What the job is

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet.

Key Responsibilities

  • Lead ongoing safety signal detection, evaluation, and benefit-risk assessments across clinical trials and postmarketing settings.
  • Serve as the primary author of safety sections in protocols, Investigator’s Brochures, CSRs, DSURs, RMPs, and regulatory documents/responses.
  • Represent Drug Safety on Global Development and Product Teams, providing expert input on safety strategy, protocol design, and regulatory interactions.
  • Prepare and lead Safety Review Committee (SRC) and Data Safety Monitoring Board (DSMB) meetings, including data analysis and presentation of safety findings.
  • Present at internal governance forums such as the Global Safety Leadership Committee (GSLC) and SRC, delivering strategic safety insights.
  • Collaborate cross-functionally with Clinical Research, Regulatory, Biostats, Medical Affairs, and external partners to align on safety deliverables.
  • Ensure data integrity and compliance in safety databases and clinical trial systems.
  • Drive innovation in safety science, including the use of real-world evidence and advanced analytics.
  • Lead process improvements and contribute to the development of safety monitoring standards and tools.
  • Mentor junior safety scientists and contribute to internal training and capability-building initiatives.
  • Support inspection readiness and contribute to successful global regulatory submissions.
  • Lead strategic planning for safety operations, including SOP updates, audits, and business continuity.

Basic Qualifications

  • MD or equivalent with 4+ years of experience in drug safety/pharmacovigilance, with a focus on clinical trials and cross-functional collaboration

Preferred Qualifications

  • MD required; completion of residency or subspecialty fellowship preferred.
  • Clinical experience in oncology, rheumatology, and/or neurology strongly preferred.
  • Minimum 5+ years of experience in drug safety/pharmacovigilance, with a focus on clinical trials and cross-functional collaboration.
  • Experience with Cell or Gene Therapy, other immunotherapies (T-cell Engagers, Checkpoint Inhibitors) and/or Inflammation therapies.
  • Proven ability to work in matrixed environments
  • Strong knowledge of global regulatory requirements (FDA, EMA, ICH, etc.).
  • Proficiency in safety databases (e.g., ARISg, Argus) and signal detection tools (e.g., Empirica, Spotfire).
  • Exceptional communication, collaboration, and project management skills.
  • High attention to detail, scientific rigor, and a proactive, solutions-oriented mindset.

For additional benefits information, visit

https://www.gilead.com/careers/compensation-benefits-and-wellbeing

  • Eligible employees may participate in benefit plans, subject to the terms and conditions of the applicable plans.

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.